A citation-based method for searching scientific literature


List of co-cited articles
558 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy.
Kerry J Savage, Nathalie A Johnson, Susana Ben-Neriah, Joseph M Connors, Laurie H Sehn, Pedro Farinha, Douglas E Horsman, Randy D Gascoyne. Blood 2009
468
53

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Nathalie A Johnson, Graham W Slack, Kerry J Savage, Joseph M Connors, Susana Ben-Neriah, Sanja Rogic, David W Scott, King L Tan, Christian Steidl, Laurie H Sehn,[...]. J Clin Oncol 2012
666
51

Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab.
Sharon Barrans, Simon Crouch, Alex Smith, Kathryn Turner, Roger Owen, Russell Patmore, Eve Roman, Andrew Jack. J Clin Oncol 2010
421
49

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.
Christine P Hans, Dennis D Weisenburger, Timothy C Greiner, Randy D Gascoyne, Jan Delabie, German Ott, H Konrad Müller-Hermelink, Elias Campo, Rita M Braziel, Elaine S Jaffe,[...]. Blood 2004
46

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival.
Nathalie A Johnson, Kerry J Savage, Olga Ludkovski, Susana Ben-Neriah, Ryan Woods, Christian Steidl, Martin J S Dyer, Reiner Siebert, John Kuruvilla, Richard Klasa,[...]. Blood 2009
433
42

Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Tina Marie Green, Ken H Young, Carlo Visco, Zijun Y Xu-Monette, Attilio Orazi, Ronald S Go, Ole Nielsen, Ole V Gadeberg, Torben Mourits-Andersen, Mikael Frederiksen,[...]. J Clin Oncol 2012
486
41

Double-hit B-cell lymphomas.
Sietse M Aukema, Reiner Siebert, Ed Schuuring, Gustaaf W van Imhoff, Hanneke C Kluin-Nelemans, Evert-Jan Boerma, Philip M Kluin. Blood 2011
474
39


MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma.
Heike Horn, Marita Ziepert, Claudia Becher, Thomas F E Barth, Heinz-Wolfram Bernd, Alfred C Feller, Wolfram Klapper, Michael Hummel, Harald Stein, Martin-Leo Hansmann,[...]. Blood 2013
388
35


Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma.
Christopher J Stasik, Hiroaki Nitta, Wenjun Zhang, Charles H Mosher, James R Cook, Raymond R Tubbs, Joseph M Unger, Tracy A Brooks, Daniel O Persky, Sarah T Wilkinson,[...]. Haematologica 2010
76
38

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
A A Alizadeh, M B Eisen, R E Davis, C Ma, I S Lossos, A Rosenwald, J C Boldrick, H Sabet, T Tran, X Yu,[...]. Nature 2000
27


B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
Matija Snuderl, Olga K Kolman, Yi-Bin Chen, Jessie J Hsu, Adam M Ackerman, Paola Dal Cin, Judith A Ferry, Nancy Lee Harris, Robert P Hasserjian, Lawrence R Zukerberg,[...]. Am J Surg Pathol 2010
253
25

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.
Andreas Rosenwald, George Wright, Wing C Chan, Joseph M Connors, Elias Campo, Richard I Fisher, Randy D Gascoyne, H Konrad Muller-Hermelink, Erlend B Smeland, Jena M Giltnane,[...]. N Engl J Med 2002
24

B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.
Shaoying Li, Pei Lin, Luis E Fayad, Patrick A Lennon, Roberto N Miranda, C Cameron Yin, E Lin, L Jeffrey Medeiros. Mod Pathol 2012
193
23

MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
Alexandra Valera, Armando López-Guillermo, Teresa Cardesa-Salzmann, Fina Climent, Eva González-Barca, Santiago Mercadal, Iñigo Espinosa, Silvana Novelli, Javier Briones, José L Mate,[...]. Haematologica 2013
170
23

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
Steven H Swerdlow, Elias Campo, Stefano A Pileri, Nancy Lee Harris, Harald Stein, Reiner Siebert, Ranjana Advani, Michele Ghielmini, Gilles A Salles, Andrew D Zelenetz,[...]. Blood 2016
22

A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.
Michael Hummel, Stefan Bentink, Hilmar Berger, Wolfram Klapper, Swen Wessendorf, Thomas F E Barth, Heinz-Wolfram Bernd, Sergio B Cogliatti, Judith Dierlamm, Alfred C Feller,[...]. N Engl J Med 2006
669
21

Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP.
Monica Testoni, Ivo Kwee, Timothy C Greiner, Santiago Montes-Moreno, Julie Vose, Wing C Chan, Annalisa Chiappella, Luca Baldini, Andrés J M Ferreri, Gianluca Gaidano,[...]. Br J Haematol 2011
41
51

Stromal gene signatures in large-B-cell lymphomas.
G Lenz, G Wright, S S Dave, W Xiao, J Powell, H Zhao, W Xu, B Tan, N Goldschmidt, J Iqbal,[...]. N Engl J Med 2008
19

The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.
Steven Le Gouill, Pascaline Talmant, Cyrille Touzeau, Anne Moreau, Richard Garand, Nadine Juge-Morineau, Fanny Gaillard, Thomas Gastinne, Noël Milpied, Philippe Moreau,[...]. Haematologica 2007
166
19

BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome.
Maria Grazia Tibiletti, Vittoria Martin, Barbara Bernasconi, Barbara Del Curto, Lorenza Pecciarini, Silvia Uccella, Giancarlo Pruneri, Maurillio Ponzoni, Luca Mazzucchelli, Giovanni Martinelli,[...]. Hum Pathol 2009
78
23

Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations.
Naoto Tomita, Mami Tokunaka, Naoya Nakamura, Kengo Takeuchi, Junki Koike, Shigeki Motomura, Ko Miyamoto, Ako Kikuchi, Rie Hyo, Yoshihiro Yakushijin,[...]. Haematologica 2009
161
17

BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.
Javeed Iqbal, Warren G Sanger, Douglas E Horsman, Andreas Rosenwald, Diane L Pickering, Bhavana Dave, Sandeep Dave, Li Xiao, Kajia Cao, Quiming Zhu,[...]. Am J Pathol 2004
197
17


Immunohistochemical detection of MYC-driven diffuse large B-cell lymphomas.
Michael J Kluk, Bjoern Chapuy, Papiya Sinha, Alyssa Roy, Paola Dal Cin, Donna S Neuberg, Stefano Monti, Geraldine S Pinkus, Margaret A Shipp, Scott J Rodig. PLoS One 2012
117
17

Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma.
Gustaaf W van Imhoff, Evert-Jan G Boerma, Bronno van der Holt, Ed Schuuring, Leo F Verdonck, Hanneke C Kluin-Nelemans, Philip M Kluin. J Clin Oncol 2006
130
16

Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma.
M H Kramer, J Hermans, E Wijburg, K Philippo, E Geelen, J H van Krieken, D de Jong, E Maartense, E Schuuring, P M Kluin. Blood 1998
369
16

MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation.
Wendy Cuccuini, Josette Briere, Nicolas Mounier, Hans-Ullrich Voelker, Andreas Rosenwald, Christer Sundstrom, Sergio Cogliatti, Edouard Hirchaud, Loic Ysebaert, Dominique Bron,[...]. Blood 2012
124
16

MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study.
Christiane Copie-Bergman, Peggy Cuillière-Dartigues, Maryse Baia, Josette Briere, Richard Delarue, Danielle Canioni, Gilles Salles, Marie Parrens, Karim Belhadj, Bettina Fabiani,[...]. Blood 2015
158
16

Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study.
Christiane Copie-Bergman, Philippe Gaulard, Karen Leroy, Josette Briere, Maryse Baia, Jean-Philippe Jais, Gilles A Salles, Françoise Berger, Corinne Haioun, Herve Tilly,[...]. J Clin Oncol 2009
93
16

MYC and aggressive B-cell lymphomas.
Graham W Slack, Randy D Gascoyne. Adv Anat Pathol 2011
97
15

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy.
William W L Choi, Dennis D Weisenburger, Timothy C Greiner, Miguel A Piris, Alison H Banham, Jan Delabie, Rita M Braziel, Huimin Geng, Javeed Iqbal, Georg Lenz,[...]. Clin Cancer Res 2009
474
15

Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.
Adam M Petrich, Mitul Gandhi, Borko Jovanovic, Jorge J Castillo, Saurabh Rajguru, David T Yang, Khushboo A Shah, Jeremy D Whyman, Frederick Lansigan, Francisco J Hernandez-Ilizaliturri,[...]. Blood 2014
305
15

Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis.
Anuradha Kanungo, L Jeffrey Medeiros, Lynne V Abruzzo, Pei Lin. Mod Pathol 2006
157
14

BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab.
Javeed Iqbal, Paul N Meyer, Lynette M Smith, Nathalie A Johnson, Julie M Vose, Timothy C Greiner, Joseph M Connors, Louis M Staudt, Lisa Rimsza, Elaine Jaffe,[...]. Clin Cancer Res 2011
126
14

High levels of nuclear MYC protein predict the presence of MYC rearrangement in diffuse large B-cell lymphoma.
Tina Marie Green, Ole Nielsen, Karin de Stricker, Zijun Y Xu-Monette, Ken H Young, Michael Boe Møller. Am J Surg Pathol 2012
102
14


MYC translocation partner gene determines survival of patients with large B-cell lymphoma with MYC- or double-hit MYC/BCL2 translocations.
Mette Ø Pedersen, Anne O Gang, Tim S Poulsen, Helle Knudsen, Anne F Lauritzen, Signe L Nielsen, Tobias W Klausen, Peter Nørgaard. Eur J Haematol 2014
93
15

Molecular diagnosis of Burkitt's lymphoma.
Sandeep S Dave, Kai Fu, George W Wright, Lloyd T Lam, Philip Kluin, Evert-Jan Boerma, Timothy C Greiner, Dennis D Weisenburger, Andreas Rosenwald, German Ott,[...]. N Engl J Med 2006
574
12


The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome.
Sharon L Barrans, Paul A S Evans, Sheila J M O'Connor, S Jane Kendall, Roger G Owen, Andrew P Haynes, Gareth J Morgan, Andrew S Jack. Clin Cancer Res 2003
106
12

Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
Kai Fu, Dennis D Weisenburger, William W L Choi, Kyle D Perry, Lynette M Smith, Xinlan Shi, Christine P Hans, Timothy C Greiner, Philip J Bierman, R Gregory Bociek,[...]. J Clin Oncol 2008
252
12

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.
Laurie H Sehn, Brian Berry, Mukesh Chhanabhai, Catherine Fitzgerald, Karamjit Gill, Paul Hoskins, Richard Klasa, Kerry J Savage, Tamara Shenkier, Judy Sutherland,[...]. Blood 2007
945
12

Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab.
Paul N Meyer, Kai Fu, Timothy C Greiner, Lynette M Smith, Jan Delabie, Randy D Gascoyne, German Ott, Andreas Rosenwald, Rita M Braziel, Elias Campo,[...]. J Clin Oncol 2011
348
12

Double-hit BCL2/MYC translocations in a consecutive cohort of patients with large B-cell lymphoma - a single centre's experience.
Mette Ø Pedersen, Anne O Gang, Tim S Poulsen, Helle Knudsen, Anne F Lauritzen, Signe L Nielsen, Uffe O Gang, Peter Nørgaard. Eur J Haematol 2012
79
15

MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab.
Anamarija M Perry, Yuridia Alvarado-Bernal, Javier A Laurini, Lynette M Smith, Graham W Slack, King L Tan, Laurie H Sehn, Kai Fu, Patricia Aoun, Timothy C Greiner,[...]. Br J Haematol 2014
131
12


Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.
Georg Lenz, George W Wright, N C Tolga Emre, Holger Kohlhammer, Sandeep S Dave, R Eric Davis, Shannon Carty, Lloyd T Lam, A L Shaffer, Wenming Xiao,[...]. Proc Natl Acad Sci U S A 2008
702
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.